Description
| Product Name | CAT.No | Size |
| Toxoplasmosis | TOXO0040 | 40T |
Product Description
The Biorex Diagnostics Toxoplasmosis Rapid Test is a rapid immunochromatographic assay designed for the qualitative detection of IgG and IgM antibodies to Toxoplasma gondii in whole blood, serum, or plasma. Early detection of Toxoplasma infection is critical, particularly in pregnant women, immunocompromised patients, and individuals undergoing routine clinical monitoring, as it helps prevent serious complications and guide timely treatment. This rapid test provides reliable and reproducible results, making it a valuable tool for hospitals, clinics, and point-of-care settings where fast and accurate screening is essential.
Key Features
- Rapid Detection – Provides results within minutes, allowing prompt clinical assessment and intervention.
- Dual Antibody Detection – Simultaneously detects IgG for past exposure and IgM for recent or acute infections, enabling comprehensive serological evaluation.
- Multiple Sample Types – Compatible with whole blood, serum, or plasma, supporting flexible testing across a variety of clinical workflows.
- Simple and User-Friendly – Requires minimal training and no specialised laboratory equipment, making it ideal for point-of-care and emergency settings.
- High Sensitivity and Specificity – Ensures confident detection of Toxoplasma antibodies, reducing false positives and negatives.
Benefits
Routine use of the Toxoplasmosis Rapid Test allows clinicians to quickly identify Toxoplasma gondii infections and differentiate between recent and past exposure. This enables timely management of high-risk patients, including pregnant women and immunocompromised individuals, reducing the likelihood of adverse health outcomes. The test’s ease of use and minimal sample handling streamline laboratory workflows, support rapid decision-making, and enhance operational efficiency in clinical environments.
By integrating this assay into prenatal screening programs, routine laboratory testing, or point-of-care monitoring, healthcare providers can improve patient outcomes and maintain high-quality care standards. Its versatility in sample types and rapid turnaround time ensures dependable results in a variety of settings, from hospitals to field screening programs. Backed by Biorex Diagnostics’ expertise in in vitro diagnostics, the Toxoplasmosis Rapid Test delivers a cost-effective, reliable, and clinically relevant solution for early detection and monitoring of Toxoplasma infections.
Contact Us for more information.